PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) by Hsu, YH









Atlas Genet Cytogenet Oncol Haematol. 2010; 14(10)   928 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
OPEN ACCESS JOURNAL AT INIST-CNRS 
PAK2 (p21 protein (Cdc42/Rac)-activated kinase 2) 
Yuan-Hao Hsu 
Department of Chemistry and Biochemistry and Pharmacology, School of Medicine, San Diego, La Jolla, 
California 92093-0601, USA (YHH) 
 
Published in Atlas Database: April 2011 
Online updated version : http://AtlasGeneticsOncology.org/Genes/PAK2ID41634ch3q29.html 
DOI: 10.4267/2042/46065 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2011 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
 
Identity 
Other names: PAK65; PAKgamma 




Pak2 gene at 193763319 to 193859670 bp from pter 
contains 96352 bases and 34 exons. Pak2 gene at the
alternative location starts at 196466728 and ends at 
196559518 bp from pter. The PAK2 gene in this 
location contains 20 exons. 
Protein 
Description 
Pak2 has an N-terminal regulatory domain and a C-
terminal catalytic domain. In the regulatory domain, 
Pak2 have several conserved regions, including an 
autoinhibitory domain (AID), a p21-binding domain 
(PBD), dimerization domain, proline-rich regions, and 
an acidic region. The schematic structure of Pak2 is 
shown in figure above. The catalytic domain of Pak is a
conserved bilobal structure in most of the protein 
kinases. 
Expression 
Pak2 is 58.8 kDa (524 residues) and expressed 
ubiquitously in mammalian cells. 
Function 
PAK activation is through disruption of autoinhibiton,  
followed by autophosphorylation. In the inactive state, 
the AID interacts with the catalytic domain to inhibit its 
kinase activity. GTP-bound Cdc42 can disrupt 
autoinhibition, which, in turn, leads to 
autophosphorylation and activation of PAK. Pak2's 
basal autophosphorylation activity is observed and 
Pak2 is autophosphorylated at 5 sites, serines 19, 20, 
55, 192 and 197. Additional three phosphorylation sites 
(serines 141 and 165 and threonine 402) are 
autophosphorylated in the presence of Cdc42(GTP) and 
ATP. Autophosphorylation of Thr402 in the activation 
loop is required for the kinase activity of Pak2. 
Pak2 can be activated in response to a lot of stresses. 
Moderate stresses, like hyperosmolarity, ionizing 
radiation, DNA-damaging agents and serum-
deprivation, induce Pak2 activation in cells and lead to 
cell cycle arrest at G2/M. Activated Pak2 inhibits 
translation by phosphorylation of various substrates. 
Pak2 has specific protein substrates, e.g. histone 4, 
myosin light chain (MLC), prolactin, c-Abl, eukaryote 
translation initiation factor 3 (eIF3), eIF4B, eIF4G, and 
Mnk1. Pak2 recognizes the consensus sequence 
(K/RRXS).  
Pak2 is the only member of the PAK family that is 
directly activated by caspase 3. When Pak2 is cleaved 
and activated by caspase 3, Pak2 promotes the 
morphological and biochemical changes of apoptosis. 
The pro-apoptosis protease, caspase 3 cleaves Pak2 
after Asp 212, and thus produces a p27 fragment 
containing primarily the regulatory domain, and a p34 
fragment containing a small piece of the regulatory 
domain and the entire catalytic domain. 
Autophosphorylation results in a constitutively active 
p34 kinase domain.  
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The Linear schematic of Pak2. Functional domains, including proline rich regions (P), acidic region (A), p21-binding domain (PBD), 
Cdc42 and Rac interaction and binding sequence (CRIB) and autoinhibitory domain (AID) are designated. Autophosphorylation sites (*) 
and caspase 3 cleavage site (v) are marked. The regulatory domain is blue; the protein kinase domain is green; the overlapping region 
between PBD and AID is pink. 
 
The nuclear import signal (245-251) is required for
nuclear localization. Disruption of the region (197-
246), containing nuclear export signal results in the 
nuclear localization of the Pak2 p34 fragment. 
Homology 
Pak1, Pak2 and Pak3 are highly homologous. The 
primary sequence of human Pak2 is 72 % identical to 
Pak1 and 71 % identical to Pak3. 
Mutations 
Note 




Huang (2004) showed Pak2 is a negative regulator of 
Myc and suggested Pak2 may be the product of a tumor 
suppressor gene. Coniglio (2008) reported Pak2 
mediates tumor invasion in breast carcinoma cells. 
Inhibition of RhoA in Pak2-depleted cells decreases 
MLC phosphorylation and restores cell invasion. Also, 
the NF2 tumor suppressor Merlin is a substrate of Pak2. 
Wilkes (2009) showed that Erbin regulates the functio  
of Merlin through Pak2 binding to Merlin. 
Immunodeficiency 
Note 
Human immunodeficiency virus type 1 HIV-1. 
Prognosis 
Human immunodeficiency virus type 1 Nef associates 
with a active Pak2 independently of binding to Nck or 
PIX. Nef recruits the GEF Vav1 to plasma membrane 
to associate with Pak2. 
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